Compare BLCO & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | MIAX |
|---|---|---|
| Founded | 1853 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.4B |
| IPO Year | 2022 | 2025 |
| Metric | BLCO | MIAX |
|---|---|---|
| Price | $17.32 | $44.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $18.45 | ★ $47.00 |
| AVG Volume (30 Days) | 389.8K | ★ 1.2M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.95 |
| Revenue | ★ $5,101,000,000.00 | $1,364,073,000.00 |
| Revenue This Year | $8.65 | N/A |
| Revenue Next Year | $5.59 | $12.20 |
| P/E Ratio | ★ N/A | $21.84 |
| Revenue Growth | 6.47 | ★ 19.65 |
| 52 Week Low | $13.77 | $32.20 |
| 52 Week High | $18.92 | $57.14 |
| Indicator | BLCO | MIAX |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 52.06 |
| Support Level | $16.26 | $41.23 |
| Resistance Level | $17.36 | $44.26 |
| Average True Range (ATR) | 0.43 | 2.01 |
| MACD | 0.03 | -0.26 |
| Stochastic Oscillator | 70.37 | 55.63 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Miami International Holdings Inc is engaged in operating regulated financial marketplaces across multiple asset classes using proprietary technology platforms. The company operates exchange markets for options, equities, futures, and international listings through its MIAX Exchanges, MIAX Futures Exchange, and the Bermuda Stock Exchange. The company operates through four reportable segments: Options, which provides trading and market data services for listed equity and ETP options; Equities, which provides trading services for U.S. equities and ETPs; Futures, which provides futures trading and clearing services through MIAX Futures; and International, which provides listing services for capital market instruments through the Bermuda Stock Exchange and The International Stock Exchange.